Qiagen, Merck Team on HPV Dx, Rx in Developing World | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen and Merck will collaborate to provide HPV screening and vaccination to women in the developing world as part of the Clinton Global Initiative, the partners said today.

The goal is to integrate their offerings and provide them for free in order to combat cervical cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.